NEW YORK, Aug. 18, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NBY, REDU, EMAN, AVGR, and CLVS.

InvestorsObserver (PRNewsfoto/InvestorsObserver)

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  • NBY: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=NBY&prnumber=081820200
  • REDU: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=REDU&prnumber=081820200
  • EMAN: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=EMAN&prnumber=081820200
  • AVGR: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=AVGR&prnumber=081820200
  • CLVS: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CLVS&prnumber=081820200

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-novabay-pharmaceuticals-rise-education-emagin-corp-avinger-inc-or-clovis-oncology-301114047.html

SOURCE InvestorsObserver